The hemodynamic effects of the administration of ionic and nonionic contrast materials into the pulmonary arteries of a canine model of acute pulmonary hypertension.
Clinical studies have shown pulmonary and right ventricular hypertension to be important factors increasing the risk to patients during pulmonary angiography. This experiment was undertaken to define the hemodynamic changes induced by the administration of contrast material into the pulmonary arteries of dogs with embolic pulmonary hypertension, and to compare the effects of ionic and nonionic agents. Ten closed-chest dogs under light halothan anesthesia were subjected to pulmonary embolization with sephadex microspheres until severe pulmonary hypertension occurred and the cardiac output decreased to 50%-60% of the pre-embolization baseline. Intra-pulmonary injections of contrast material were performed in eight animals while hemodynamic indices were measured. Sodium methylglucamine diatrizoate induced severe, transient, hypotension associated with a large decrease in systemic vascular resistance and little change in the cardiac output. Hypotension is especially undesirable in the presence of pulmonary hypertension because it worsens the preexisting coronary ischemia and compromised right ventricular function. No elevation in mean pulmonary artery pressure was seen, and pulmonary vascular resistance decreased. Iohexol induced milder effects, perhaps because it exerts a less severe systemic vasodilatory effect and is not a negative inotrope. These findings suggest iohexol may be safer in the high risk patient, however, these data may not be directly applied to unanesthetized humans.
Rees
C R
CR
Department of Radiology, University of Texas Health Science Center, San Antonio 78284.
Palmaz
J C
JC
Garcia
O
O
Alvarado
R
R
Siegle
R L
RL
D000208:Acute Disease; D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage*; D003973:Diatrizoate / Q000008:administration & dosage*; D003974:Diatrizoate Meglumine / Q000008:administration & dosage*; D004285:Dogs; D004338:Drug Combinations / Q000008:administration & dosage; D006439:Hemodynamics / Q000187:drug effects*; D006976:Hypertension, Pulmonary / Q000000981:diagnostic imaging* / Q000503:physiopathology; D007269:Injections, Intra-Arterial; D007472:Iohexol / Q000008:administration & dosage*; D011651:Pulmonary Artery; D011859:Radiography
D003287:Contrast Media; D004338:Drug Combinations; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D007472:Iohexol; C027278:urovision